Day: February 9, 2020

­­­Maha Energy AB (publ)Strandvagen 5ASE-114 51 Stockholmwww.mahaenergy.caPress releaseStockholmFebruary 9, 2020Maha Energy announce positive 107D well test results107D (Tartaruga)The well test on 107D is now complete and Maha is pleased to report the following (gross volume) results:On Free FlowOil Rate: 626 BOPDGas Rate: 227 MSCFPDWater/Emulsion: 177 BPDOn Pump (reduced power)*Oil Rate: 939 BOPDGas Rate: 343 MSCFPDWater/Emulsion: 304 BPDDuring the 20-day test period, which was split between free flowing and pumping operations, a steady trend of increasing oil and gas volumes were recorded. During the same period, the water and oil emulsion percentage was steadily reducing.Jonas Lindvall, CEO of Maha commented: “The results from the 107D well test is above our expectations. Prior to the horizontal sidetrack, the 107D...

Oxurion NV – Expert Presentation of Positive Topline Data from a Phase 1 Study evaluating THR-687 for the treatment of DME,at Angiogenesis, Exudation, and Degeneration 2020 ConferencePhase 2 study with THR-687 in treatment naïve DME patients to start in H2 2020Leuven, Belgium, 9 February 2020 – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation therapies designed to treat patients with diabetic eye disease, today announces that further positive topline data from a Phase 1 study with THR-687, a novel, potent, pan-RGD integrin antagonist for the treatment of Diabetic Macular Edema (DME) was presented by Arshad Khanani, M.D., M.A., Director of Clinical Research at Sierra Eye Associates, Reno, Nevada, US at the Angiogenesis, Exudation, and Degeneration 2020 conference on February...

SASKATOON, Saskatchewan, 09 févr. 2020 (GLOBE NEWSWIRE) — Cameco (TSX: CCO; NYSE: CCJ) a annoncé aujourd’hui ses résultats financiers et d’exploitation consolidés pour le quatrième trimestre et l’exercice se terminant le 31 décembre 2019 conformément aux Normes internationales d’information financière (IFRS).« Comme prévu, nous avons connu une très bonne fin d’année 2019, a déclaré le président et chef de la direction de Cameco, Tim Gitzel. Au cours du quatrième trimestre, nous avons livré 14 millions de livres d’uranium, enregistrant, pour 2019, un montant de 527 millions de dollars en trésorerie d’exploitation. Ce sont des chiffres qui démontrent...